Skip to main content
    O

    Olema Pharmaceuticals Inc (OLMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.87
    +0.07 (+1.03%)

    Market Cap: $594.98M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    42%(10/24)
    Avg Surprise
    -21.96%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.63
    Range$-0.73 - $-0.50
    9 analysts
    EPS Revisions
    1
    0
    7d
    1
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.58-9.5%
    60d ago$-0.58-9.5%
    30d ago$-0.65+1.7%
    7d ago$-0.63-0.5%
    Current$-0.63
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.64
    Range$-0.96 - $-0.18
    9 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.64---
    Sep 26EST
    		-$-0.63---
    Jun 26
    Reported Aug 10
    		$-0.61$-0.53-15.09%Miss-19.6%
    Mar 26
    Reported May 12
    		$-0.52$-0.54+3.70%Beat-44.4%
    Dec 25
    Reported Mar 16
    		$-0.50$-0.52+3.28%Beat+1.1%
    Sep 25
    Reported Nov 10
    		$-0.49$-0.45-8.89%Miss+18.3%
    Jun 25
    Reported Aug 11
    		$-0.51$-0.44-15.91%Miss+5.6%
    Mar 25
    Reported May 13
    		$-0.36$-0.46+21.74%Beat+35.7%
    Dec 24
    Reported Mar 18
    		$-0.51$0.17-394.46%Miss-4.1%
    Sep 24
    Reported Nov 12
    		$-0.60$-0.57-5.26%Miss-25.0%
    Jun 24
    Reported Aug 6
    		$-0.54$-0.54+0.00%Beat-10.2%
    Mar 24
    Reported May 8
    		$-0.56$-0.55-1.82%Miss+20.0%
    Dec 23
    Reported Mar 11
    		$-0.49$-0.48-2.08%Miss+24.6%
    Sep 23
    Reported Nov 7
    		$-0.48$-0.51+5.88%Beat+15.8%
    Jun 23
    Reported Aug 8
    		$-0.49$-0.71+30.99%Beat+40.2%
    Mar 23
    Reported May 9
    		$-0.70$-0.69-1.45%Miss-20.7%
    Dec 22
    Reported Mar 9
    		$-0.65$-0.65+0.00%Beat-20.4%
    Sep 22
    Reported Nov 8
    		$-0.57$-0.78+26.92%Beat-26.7%
    Jun 22
    Reported Aug 9
    		$-0.82$-0.66-24.24%Miss-95.2%
    Mar 22
    Reported May 9
    		$-0.58$-0.60+3.33%Beat-48.7%
    Dec 21
    Reported Feb 28
    		$-0.54$-0.49-10.20%Miss-8.0%
    Sep 21
    Reported Nov 10
    		$-0.45$-0.43-4.65%Miss-1400.0%
    Jun 21
    Reported Aug 10
    		$-0.42$-0.38-10.53%Miss-
    Mar 21
    Reported May 11
    		$-0.39$-0.27-44.44%Miss-
    Dec 20
    Reported Mar 17
    		$-0.50$-0.18-177.78%Miss-
    Sep 20
    Reported Nov 19
    		$-0.03N/A+94.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio-3.23EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-52.70%ROIC-40.36%
    Financial Health
    Debt/Equity0.01xInterest CoverageN/A
    Current Ratio8.86xQuick Ratio8.86x
    Trading Statistics
    Beta2.01Avg Volume1.32M
    52-Week High$36.2652-Week Low$6.61

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.60
    SMA 20$8.29
    SMA 50$9.73
    SMA 200$15.10
    EMA 10$7.54
    EMA 20$8.19
    EMA 50$9.41
    EMA 200$12.31

    MACD

    Line: -0.81Signal: -0.72Hist: -0.10

    ADX

    ADX: 39.4+DI: 6.3-DI: 33.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down96.0
    PSAR$7.55

    Bollinger Bands

    Upper Band$10.05
    Lower Band$6.53
    %B Position4249%(Upper)
    Band Width0.10

    RSI (14-Day)

    Oversold
    19.0

    Momentum Oscillators

    Stoch %K6.9
    Stoch %D5.0
    Williams %R-88.4
    ROC (10d)-16.9%
    Momentum-1.40
    CCI (20d)-143.6
    MFI (14d)10.2

    Volatility Measures

    ATR (14d)$0.48(6.9%)
    StdDev (20d)0.88
    Hist Vol42.5%(High)

    Volume Flow

    VWAP$6.84
    OBV52.0M
    AD Line-54.3M
    CMF (20d)-0.302

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio0.8x
    VWMA (20d)$8.37

    Pivot Points

    R3$7.64
    R2$7.39
    R1$7.10
    Pivot Point$6.85
    S1$6.56
    S2$6.31
    S3$6.02

    Advanced Oscillators

    TSI-52.87
    Ultimate Osc33.0
    KST-242.04

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$364,000$0$0$0$1.88M$0
    Cost of Revenue$0$0$187,000$0$0$0$182,000$0$0$0$88,000$0
    Gross Profit$0$0$-187,000$0$0$0$182,000$0$0$0$1.80M$0
    Operating Expenses$67.18M$57.99M$50.08M$45.88M$47.86M$34.87M$36.77M$37.62M$33.53M$34.34M$30.42M$23.34M
    R&D$57.78M$49.23M$43.22M$39.95M$43.90M$30.62M$32.30M$33.23M$29.11M$29.88M$25.87M$19.45M
    SG&A$9.39M$8.75M$6.86M$5.93M$3.96M$4.25M$4.47M$4.39M$4.42M$4.46M$4.54M$3.89M
    Operating Income$-67,179,000$-57,986,000$-50,084,000$-45,877,000$-47,864,000$-34,873,000$-36,768,000$-37,621,000$-33,530,000$-34,339,000$-30,416,000$-23,342,000
    Interest Income$4.51M$4.78M$4.01M$3.65M$4.04M$4.52M$3.29M$2.93M$3.11M$3.35M$3.55M$1.92M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-63,200,000$-53,089,000$-46,061,000$-42,217,000$-43,784,000$-30,389,000$-33,567,000$-34,555,000$-30,382,000$-30,970,000$-26,772,000$-21,502,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-63,200,000$-53,089,000$-46,061,000$-42,217,000$-43,784,000$-30,389,000$-33,567,000$-34,555,000$-30,382,000$-30,970,000$-26,772,000$-21,502,000
    EBITDA$-67,605,000$-57,746,000$-49,884,000$-45,822,000$-47,694,000$-34,785,000$-36,745,000$-37,388,000$-33,396,000$-34,234,000$-30,235,000$-23,331,000
    EBIT$-67,707,000$-57,865,000$-50,071,000$-45,865,000$-47,826,000$-34,913,000$-36,861,000$-37,483,000$-33,490,000$-34,322,000$-30,323,000$-23,421,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OLMA

    News

    Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Has Consensus Price Target of $40.60 According to Brokerages

    Olema Pharmaceuticals (NASDAQ:OLMA) has a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $40.60. Despite recent reductions in price targets by several brokerages...

    MarketBeat•10/14/26•Somewhat-Bearish

    Olema Pharmaceuticals, Inc. (OLMA) Stock Price, News, Quote & History

    This Yahoo Finance article provides a detailed overview of Olema Pharmaceuticals, Inc. (OLMA), including its current stock price, trading activity, historical performance...

    Yahoo! Finance Canada•10/5/26•Neutral

    Mammo 2026: OncoDaily and Olema Pharmaceuticals Bring Global Breast Cancer Perspectives Together

    OncoDaily and Olema Pharmaceuticals are collaborating for Mammo 2026, a virtual global congress on breast cancer care taking place on October 8-9, 2026. Olema Oncology is a Bronze Sponsor...

    Oncodaily•9/29/26•Bullish

    Bank of America Corp DE Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA

    Bank of America Corp DE has acquired a new stake of 334,875 shares, valued at approximately $4.19 million, in Olema Pharmaceuticals Inc. during the second quarter of 2026. This investment makes Bank of America Corp DE...

    MarketBeat•9/29/26•Neutral

    Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.1% - Time to Sell?

    Olema Pharmaceuticals (NASDAQ:OLMA) experienced a 7.1% drop in shares, trading at $8.95 with significantly reduced volume. Despite several analyst price target cuts...

    MarketBeat•9/23/26•Bearish

    OLMA Valuation and Fair Value

    P/E
    -3.2x
    P/B
    1.7x
    See GNG's fair value

    OLMA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -40.4%
    ROE
    -52.7%

    OLMA Competitors

    CompanyTicker
    Phathom Pharmaceuticals IncPHAT
    Ironwood Pharmaceuticals IncIRWD
    Sophia Genetics SASOPH
    Weave Communications IncWEAV
    ProKidney Corp.PROK
    Nuvectis Pharma IncNVCT
    Zevra Therapeutics Inc.ZVRA
    Climb Bio IncCLYM

    Sector: Healthcare

    OLMA Analyst Ratings

    Consensus
    Buy
    Analysts
    12
    Strong Buy
    2
    Buy
    9
    Hold
    1
    Sell
    0
    Strong Sell
    0

    OLMA Bull Case vs Bear Case

    Bull case

    • 91.7% of OLMA's analyst ratings are Buy or Strong Buy.

    Bear case

    • OLMA beat EPS estimates in 37.5% of its last 8 reported quarters.

    OLMA Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -51.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.63
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 7 down

    Frequently Asked Questions About OLMA

    Does OLMA pay dividends?

    Olema Pharmaceuticals Inc (OLMA) does not currently pay a regular dividend.

    What is OLMA's market cap?

    Olema Pharmaceuticals Inc (OLMA) has a market capitalization of $594.98M with a current stock price of $6.87.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In